Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Counting the burden: atopic dermatitis and health-related quality of life
Atopic dermatitis is the most prevalent chronic inflammatory skin condition globally. The
burden of atopic dermatitis on children and adults is extensive and there is also significant …
burden of atopic dermatitis on children and adults is extensive and there is also significant …
Interleukin 17A: toward a new understanding of psoriasis pathogenesis
Molecular and cellular understanding of psoriasis pathogenesis has evolved considerably
over the last 30 years beginning in the early 1980s when psoriasis was thought to be a skin …
over the last 30 years beginning in the early 1980s when psoriasis was thought to be a skin …
[HTML][HTML] Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
Background Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, has
shown superior efficacy to etanercept with similar safety in moderate to severe plaque …
shown superior efficacy to etanercept with similar safety in moderate to severe plaque …
Comparison of long‐term drug survival and safety of biologic agents in patients with psoriasis vulgaris
Background Drug survival (time to drug discontinuation) has recently emerged as an
important parameter reflecting the long‐term therapeutic performance in a real‐life setting …
important parameter reflecting the long‐term therapeutic performance in a real‐life setting …
PASI 90 response: the new standard in therapeutic efficacy for psoriasis
In a non‐life‐threatening disease such as psoriasis, treatment goals should be referred to
the improvement in severity and extent of the disease and their impact on patients' perceived …
the improvement in severity and extent of the disease and their impact on patients' perceived …
Malignancy risk and recurrence with psoriasis and its treatments: a concise update
Psoriasis is a common inflammatory cutaneous disease that affects approximately 120
million people worldwide. Systemic treatments have significantly improved disease burden …
million people worldwide. Systemic treatments have significantly improved disease burden …
Hidradenitis suppurativa (HS) prevalence, demographics and management pathways in Australia: a population-based cross-sectional study
Background Hidradenitis Suppurativa (HS) is a painful, chronic inflammatory skin disease.
Global estimates of prevalence vary between 0.03% and 4% of the population. Our main aim …
Global estimates of prevalence vary between 0.03% and 4% of the population. Our main aim …
[HTML][HTML] Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis …
Background Psoriasis treatments lack durable efficacy and have inconvenient
administration, highlighting the need for new therapies. Objective To evaluate the efficacy …
administration, highlighting the need for new therapies. Objective To evaluate the efficacy …
Psoriatic arthritis for dermatologists
Psoriatic arthritis (PsA) affects up to one-third of patients with psoriasis. It is the major
comorbidity of psoriasis because of the likelihood that loss of function and permanent …
comorbidity of psoriasis because of the likelihood that loss of function and permanent …
JAK inhibitors in psoriatic disease
Psoriasis is now considered to be the cutaneous phenotype of a systemic inflammatory
condition, recognized under the term Psoriatic Disease (PsD). PsD has several …
condition, recognized under the term Psoriatic Disease (PsD). PsD has several …